Up-regulated expression of type II very low density lipoprotein receptor correlates with cancer metastasis and has a potential link to β-catenin in different cancers

BMC Cancer

Volumn 10, Issue 1, 2010, Pages

  He, Lei ^a   Lu, Yanjun ^a   Wang, Peng ^a   Zhang, Jun ^a   Yin, Chuanchang ^a   Qu, Shen ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN RECEPTOR; VERY LOW DENSITY LIPOPROTEIN RECEPTOR II; LIGAND; LOW DENSITY LIPOPROTEIN RECEPTOR; VERY LOW DENSITY LIPOPROTEIN RECEPTOR TYPE II, HUMAN;

ADULT; ARTICLE; BREAST CANCER; CANCER STAGING; CELLULAR DISTRIBUTION; CLINICAL FEATURE; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MIDDLE AGED; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECEPTOR UPREGULATION; STOMACH CANCER; WESTERN BLOTTING; AGED; BIOSYNTHESIS; BREAST TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION; LUNG TUMOR; METABOLISM; METHODOLOGY; SIGNAL TRANSDUCTION; STOMACH TUMOR; UPREGULATION;

AGED; BETA CATENIN; BREAST NEOPLASMS; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LIGANDS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; RECEPTORS, LDL; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; UP-REGULATION;

EID: 78049348481     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-601     Document Type: Article

References (36)

1. Takahashi S, Kawarabayasi Y, Nakai T, Sakai J, Yamamoto T: Rabbit very low density lipoprotein receptor: a low density lipoprotein receptor-like protein with distinct ligand specificity. Proc Natl Acad Sci 1992, 89:9252-9256
2. Webb JC, Patel DD, Jones MD, Knight BL, Soutar AK: Characterization and tissue-specific expression of the human 'very low density lipoprotein (VLDL) receptor' mRNA. Hum Mol Genet 1994, 3:531-537
3. Masuzaki H, Jingami H, Matsuoka N, Matsuoka N, Nakagawa O, Ogawa Y, Mizuno M, Yoshimasa Y, Yamamoto T, Nakao K: Regulation of very-lowdensity Lipoprotein receptor in hypertrophic rat heart. Circ Res 1996, 78:8-14
4. Takahashi S, Suzuki J, Kohno M, Oida K, Tamai T, Miyabo S, Yamamoto T, Nakai T: Enhancement of the binding of triglyceride-rich lipoproteins to the very low density lipoprotein receptor by apolipoprotein E and lipoprotein lipase. J Biol Chem 1995, 270:15747-15754
5. Battey FD, Gåfvels ME, FitzGerald DJ, Argraves WS, Chappell DA, Strauss JF, Strickland DK: The 39-kDa receptor-associated protein regulates ligand binding by the very low density lipoprotein receptor. J Biol Chem 1994, 269:23268-23273
6. Mikhailenko I, Krylov D, Argraves KM, Roberts DD, Liau G, Strickland DK: Cellular internalization and degradation of thrombospondin-1 is mediated by the amino-terminal heparin binding domain (HBD). High affinity interaction of dimeric HBD with the low density lipoprotein receptor-related protein. J Biol Chem 1997, 272:6784-6791
7. Argraves KM, Battey FD, MacCalman CD, McCrae KR, Gåfvels M, Kozarsky KF, Chappell DA, Strauss JF, Strickland DK: The very low density lipoprotein receptor mediates the cellular catabolism of lipoprotein lipase and urokinase-plasminogen activator inhibitor type I complexes. J Biol Chem 1995, 270:26550-26557
8. Kasza A, Petersen HH, Heegaard CW, Oka K, Christensen A, Dubin A, Chan L, Andreasen PA: Specificity of serine proteinase/serpin complex binding to very-low-density lipoprotein receptor and alpha2-macroglobulin receptor/low-density-lipoprotein-receptor-related protein. Eur J Biochem 1997, 248:270-281
9. Stolt PC, Bock HH: Modulation of lipoprotein receptor functions by intracellular adaptor proteins. Cell Signal 2006, 18:1560-1571
10. Webb DJ, Nguyen DH, Sankovic M, Gonias SL: The very low density lipoprotein receptor regulates urokinase receptor catabolism and breast cancer cell motility in vitro. J Biol Chem 1999, 274:7412-7420
11. Andreasen PA, Kjøller L, Christensen L, Duffy MJ: The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer 1997, 72:1-22
12. Iijima H, Miyazawa M, Sakai J, Magoori K, Ito MR, Suzuki H, Nose M, Kawarabayasi Y, Yamamoto TT: Expression and characterization of a very low density lipoprotein receptor variant lacking the O-linked sugar region generated by alternative splicing. J Biochem 1998, 124:747-755
13. Nakamura Y, Yamamoto M, Kumamaru E: Very low-density lipoprotein receptor in fetal intestine and gastric adenocarcinoma cells. Arch Pathol Lab Med 2000, 124:119-122
14. Wada Y, Homma Y, Nakazato K, Ishibashi T, Maruyama Y: Effect of overexpression of very low density lipoprotein receptor on cell growth. Heart Vessels 2000, 15:74-80
15. Ozawa M, Ringwald M, Kemler R: Uvomorulin-catenin complex formation is regulated by a specific domain in the cytoplasmic region of the cell adhesion molecule. Proc Natl Acad Sci 1990, 87:4246-4250
16. Polakis P: Wnt signaling and cancer. Genes Dev 2000, 14:1837-1851
17. Clements WM, Wang J, Sarnaik A, Kim OJ, MacDonald J, Fenoglio Preiser C, Groden J, Lowy AM: β-Catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer. Cancer Res 2002, 62:3503-3506
18. Chen Y, Hu Y, Lu K, Flannery JG, Ma JX: Very low density lipoprotein receptor, a negative regulator of the wnt signaling pathway and choroidal neovascularization. J Biol Chem 2007, 282:34420-34428
19. Nakamura Y, Yamamoto M, Kumamaru E: Significance of the variant and full-length forms of the very low density lipoprotein receptor in brain. J Brain Res 2001, 922:209-215
20. Maitra A, Ashfaq R, Gunn CR, Rahman A, Yeo CJ, Sohn TA, Cameron JL, Hruban RH, Wilentz RE: Cyclooxygenase 2 expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia: an immunohistochemical analysis with automated cellular imaging. Am J Clin Pathol 2002, 118:194-201
21. Yang P, Liu Z, Wang H, Tian J, Li Y, Zong Y, Qu S: Enhanced activity of very low density lipoprotein receptor II promotes SGC7901 cell proliferation and migration. Life Sci 2009, 84:402-408
22. Strickland DK, Gonias SL, Argraves WS: Diverse roles for the LDL receptor family. Trends Endocrinol Metab 2002, 13:66-74
23. Nykjaer A, Willnow TE: The low-density lipoprotein receptor gene family: a cellular Swiss army Knife? Trends in Cell Biology 2002, 12:273-280
24. Schneider WJ, Nimpf J: LDL receptor relatives at the crossroad of endocytosis and signaling. Cell Mol Life Sci 2003, 60:892-903
25. Conese M, Nykjaer A, Petersen CM, Cremona O, Pardi R, Andreasen PA, Gliemann J, Christensen EI, Blasi F: alpha-2 Macroglobulin receptor/Ldl receptor related protein(Lrp) dependent internalization of the urokinase receptor. J Cell Biol 1995, 131:1609-1622
26. Heegaard CW, Simonsen AC, Oka K, Kjøller L, Christensen A, Madsen B, Ellgaard L, Chan L, Andreasen PA: Very low density lipoprotein receptor binds and mediates endocytosis of urokinase-type plasminogen activator-type-1 plasminogen activator inhibitor complex. J Biol Chem 1995, 27:20855-20861
27. Webb DJ, Nguyen DH, Sankovic M, Gonias SL: The very low density lipoprotein receptor regulates urokinase receptor catabolism and breast cancer cell motility in vitro. J Biol Chem 1999, 274:7412-7420
28. Takada H, Imoto I, Tsuda H, Nakanishi Y, Sakakura C, Mitsufuji S, Hirohashi S, Inazawa J: Genomic loss and epigenetic silencing of very-low-density lipoprotein receptor involved in gastric carcinogenesis. Oncogene 2006, 25:6554-6562
29. Nakamura Y, Yamamoto M, Kumamaru E: A variant very low density lipoprotein receptor lacking 84 base pairs of O-linked sugar domain in the human brain myelin. Brain Res 1998, 793:47-53
30. Deguchi K, Inoue K, Avila WE, Lopez-Terrada D, Antalffy BA, Quattrocchi CC, Sheldon M, Mikoshiba K, D'Arcangelo G, Armstrong DL: Reelin and disabled-1 expression in developing and mature human cortical neurons. J Neuropathol Exp Neurol 2003, 62:676-684
31. Homayouni R, Magdaleno S, Keshvara L, Rice DS, Curran T: Interaction of Disabled-1 and the GTPase activating protein Dab2IP in mouse brain. Brain Res Mol Brain Res 2003, 115:121-129
32. Nakamura Y, Yamamoto M, Kumamaru E: Significance of the variant and full-length forms of the very low density lipoprotein receptor in brain. Brain Res 2001, 922:209-215
33. Martensen PM, Oka K, Christensen L, Rettenberger PM, Petersen HH, Christensen A, Chan L, Heegaard CW, Andreasen PA: Breast carcinoma epithelial cells express a very low-density lipoprotein receptor variant lacking the O-linked glycosylation domain encoded by exon 16, but with full binding activity for serine proteinase/serpin complexes and Mr-40,000 receptor-associated protein. Eur J Biochem 1997, 248:583-591
34. Di Y, Liu Z, Tian J, Zong Y, Yang P, Qu S: TFPI or uPA-PAI-1 complex affect cell function through expression variation of type II very low density lipoprotein receptor. FEBS Lett 2010, 548:3469-3473
35. Logan CY, Nusse R: The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 2004, 20:781-810
36. Easwaran V, Lee SH, Inge L, Guo L, Goldbeck C, Garrett E, Wiesmann M, Garcia PD, Fuller JH, Chan V, Randazzo F, Gundel R, Warren RS, Escobedo J, Aukerman SL, Taylor RN, Fantl WJ: beta-Catenin regulates vascular endothelial growth factor expression in colon cancer. Cancer Res 2003, 63:3145-3153